Death or bronchopulmonary dysplasia at 36 weeks PMA · health problem or population
It is very uncertain whether summary of Findings Table ‐ Low changes death or BPD at 36 weeks PMA compared with moderate‐high nasal continuous positive airway pressure levels (very low certainty).
1 finding from 1 review
BPD at 28 days · health problem or population
The review found no eligible studies for this question.
2 findings from 1 review
BPD (36 weeks' PMA) · health problem or population
It is very uncertain whether summary of Findings Table ‐ Low changes BPD, defined as supplemental oxygen or positive pressure support use… compared with moderate‐high nasal continuous positive airway pressure levels (very low certainty).
1 finding from 1 review
Treatment failure or need for mechanical ventilation · health problem or population
It is very uncertain whether summary of Findings Table ‐ Low changes treatment failure or need for mechanical ventilation compared with moderate‐high nasal continuous positive airway pressure levels (very low certainty).
2 findings from 1 review
Mortality before hospital discharge · health problem or population
It is very uncertain whether summary of Findings Table ‐ Low changes mortality, by hospital discharge compared with moderate‐high nasal continuous positive airway pressure levels (very low certainty).
2 findings from 1 review
Moderate‐severe neurodevelopmental impairment at 18 to 26 months ‐ not measured · health problem or population
The review found no eligible studies for this question.
2 findings from 1 review
no estimate extracted
Studies not reported
No studies found
no estimate extracted
Studies not reported
No studies found
Bronchopulmonary dysplasia/chronic lung disease · health problem or population
It is very uncertain whether summary of Findings Table ‐ Low changes BPD, defined as supplemental oxygen or positive pressure support use… compared with moderate‐high nasal continuous positive airway pressure levels (very low certainty).
1 finding from 1 review
Combined outcome of mortality or BPD at 36 weeks' PMA · health problem or population
It is very uncertain whether summary of Findings Table ‐ Low changes death or BPD at 36 weeks' PMA compared with moderate‐high nasal continuous positive airway pressure levels (very low certainty).
1 finding from 1 review
Heart rate · term newborns (≥ 37 completed weeks' postmenstrual age) and preterm infants (< 37 completed weeks' postmenstrual age) up to maximum of 44…
1 finding from 1 review
Duration of crying (seconds) · term newborns (≥ 37 completed weeks' postmenstrual age) and preterm infants (< 37 completed weeks' postmenstrual age) up to maximum of 44…
1 finding from 1 review
Percentage of time crying · term newborns (≥ 37 completed weeks' postmenstrual age) and preterm infants (< 37 completed weeks' postmenstrual age) up to maximum of 44…
1 finding from 1 review
Neonatal Infant Pain Scale (NIPS) · term newborns (≥ 37 completed weeks' postmenstrual age) and preterm infants (< 37 completed weeks' postmenstrual age) up to maximum of 44…
1 finding from 1 review
Neonatal Facial Coding Score (NFCS) (Breastfeeding versus control) · term newborns (≥ 37 completed weeks' postmenstrual age) and preterm infants (< 37 completed weeks' postmenstrual age) up to maximum of 44…
1 finding from 1 review
Douleur Aigue du Nouveau‐né (DAN) scale · term newborns (≥ 37 completed weeks' postmenstrual age) and preterm infants (< 37 completed weeks' postmenstrual age) up to maximum of 44…
1 finding from 1 review
Any adverse outcome · term newborns (≥ 37 completed weeks' postmenstrual age) and preterm infants (< 37 completed weeks' postmenstrual age) up to maximum of 44…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of infants who achieve seizure control after the first loading dose of ASM · neonates with clinically diagnosed seizures
It is very uncertain whether summary of findings table ‐ Phenytoin changes proportion of infants who achieve seizure control after the first… compared with lorazepam (very low certainty).
1 finding from 1 review
Proportion of infants who achieve seizure control after maximal loading dose of ASM · neonates with clinically diagnosed seizures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality or neurodevelopmental disability at 18 to 24 months' corrected age ‐ not reported · neonates with clinically diagnosed seizures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality before hospital discharge · neonates with clinically diagnosed seizures
It is very uncertain whether summary of findings table ‐ Phenytoin changes mortality before hospital discharge compared with lorazepam (very low certainty).
1 finding from 1 review
Proportion of infants who develop sedation or drowsiness · neonates with clinically diagnosed seizures
It is very uncertain whether summary of findings table ‐ Phenytoin changes proportion of infants who develop sedation or drowsiness compared with lorazepam (very low certainty).
1 finding from 1 review